Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyratech Com Shares Regulatory News (TYRU)

  • There is currently no data for TYRU

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Vamousse at Walmart and Cardinal Health USA

2 Feb 2015 07:00

RNS Number : 6722D
TyraTech, Inc.
02 February 2015
 



TyraTech, Inc.

("TyraTech" or the "Company")

 

Vamousse® head lice protection shampoo coming to Walmart stores in the USA

Vamousse® head lice products distributed by Cardinal Health in the USA

 

TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is pleased to announce that its Vamousse head lice Protection Shampoo will be available at Walmart stores nationwide in the USA from April 2015 and that its Vamousse head lice products are now distributed by Cardinal Health, the third biggest distributor of pharmaceutical products in the USA.

 

This new listing for Vamousse Protection Shampoo at Walmart comes a year after the successful launch of the Vamousse Treatment product in Walmart stores in the USA. Vamousse head lice Protection Shampoo has been specifically designed to eliminate any stray lice on the head before a full infestation can take hold, which typically takes 2 to 4 weeks to show up. With its innovative, non-toxic formula, Vamousse head lice Protection Shampoo is a safe and efficacious alternative to synthetic pesticide-based products.

 

The current head lice market in the USA, estimated by management at $150m, is mainly driven by treatment products that are used on a reactive basis, when children are discovered to be hosting head lice and their eggs. Management believes there is potentially a much bigger untapped market of products that protect children and families at risk of infestation.

 

The Company is also pleased to announce that its Vamousse range of products is now distributed by Cardinal Health, the third biggest distributor of pharmaceutical products in the USA. This important listing with Cardinal Health will present the opportunity for Vamousse to reach more than 9,000 independent retail pharmacies in the USA. This agreement follows the distribution for Vamousse obtained with McKesson at the end of last year. McKesson is the biggest distributor in the USA and serves more than 12,000 independently owned pharmacies. 

 

Vamousse products are also available on amazon.com and drugstore.com in the USA and at Boots, Superdrug, Sainsbury's, Tesco, and Rowlands in the UK as well as other independent pharmacies.

 

Bruno Jactel, Chief Executive Officer, said: "I am very pleased with the rapid expansion of our distribution network for Vamousse and am delighted with the national launch of our Vamousse Protection Shampoo at Walmart. We are already receiving very positive feedback from happy parents who have used Vamousse head lice Protection Shampoo on their children, telling us that despite major lice outbreaks in respective classrooms, their children have remained lice-free. Our safe, non-toxic shampoo is a breakthrough in lice protection that represents significant opportunities for the Vamousse brand and for TyraTech."

 

Further information on Vamousse™ is available on the Company's website at http://www.vamousselice.com/

 

 

TyraTech Inc.Bruno Jactel, Chief Executive Officer

Vince Morgus, Chief Financial Officer & Treasurer

 

 

 

Tel: +1 919 415 4340

Tel: +1 919 415 4287

SPARK Advisory Partners Limited, Nominated Adviser Matt Davis / Mark Brady

 

Tel: +44203 368 3552

Tel: +44203 368 3551

 

Allenby Capital Limited , Joint BrokerChris Crawford

 

Tel: +44 20 3328 5656

Whitman Howard Limited, Joint BrokerRanald Mc-Gregor Smith / Niall Devins

 

Tel: +44 20 7087 4555

 

Walbrook, Financial PR and IRBob Huxford /Guy McDougall

 

Tel: +44 20 7933 8792

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCZMGFMVGDGKZM
Date   Source Headline
31st Oct 20183:01 pmRNSResult of Special Meeting, Cancellation from AIM
25th Oct 20187:00 amRNSSpecial Meeting and Acquisition Update
18th Oct 20183:00 pmRNSNominee accounts
9th Oct 20182:23 pmRNSPosting of Proxy Statement and Timetable Update
5th Oct 201810:05 amRNSUpdate
28th Sep 20184:35 pmRNSPrice Monitoring Extension
28th Sep 20182:06 pmRNSSecond Price Monitoring Extn
28th Sep 20182:00 pmRNSPrice Monitoring Extension
28th Sep 201811:05 amRNSSecond Price Monitoring Extn
28th Sep 201811:00 amRNSPrice Monitoring Extension
28th Sep 20189:05 amRNSSecond Price Monitoring Extn
28th Sep 20189:00 amRNSPrice Monitoring Extension
28th Sep 20188:50 amRNSInterim Results
28th Sep 20187:00 amRNSConditional Merger Agreement Signed with AMVAC
23rd May 20187:00 amRNSFinal Results
9th May 20187:00 amRNSProgress in 2018 on products and milestones
3rd May 20187:00 amRNSChange of Adviser
24th Jan 20185:44 pmRNSHolding(s) in Company
18th Jan 20187:00 amRNSHolding(s) in Company
15th Jan 20187:00 amRNSResult of Tender Offer
11th Jan 20181:08 pmRNSTR-1
9th Jan 20185:01 pmRNSTR-1
5th Jan 20187:00 amRNSResult of Tender Offer
28th Dec 20177:00 amRNSResult of Special Meeting
4th Dec 20177:00 amRNSTender Offer to Shareholders and Notice of Meeting
12th Sep 20177:00 amRNSInterim Results for Six Months Ended 30 June 2017
24th Aug 20177:00 amRNSCOMPANY UPDATE AND DATE OF INTERIM RESULTS
4th Jul 20172:29 pmRNSJoint Development and License Agreement
29th Jun 20177:00 amRNSResult of AGM
7th Jun 20177:00 amRNSTYR TR-1: Notification of major interest in shares
9th May 20177:00 amRNSResults for the Year Ended 31 December 2016
28th Apr 20173:24 pmRNSFurther re Notice of Final Results
22nd Mar 20178:57 amRNSTR-1: Notification of major interest in shares
9th Feb 20177:00 amRNSPre-close Trading Update
19th Sep 20163:59 pmRNSDirector/PDMR Shareholding
15th Sep 20161:18 pmRNSDirectors' Dealings
13th Sep 20167:00 amRNSInterim Results for Six Months Ended 30 June 2016
28th Jul 20167:00 amRNSPre Close Trading Update
8th Jun 20163:22 pmRNSResult of AGM and Board Change
22nd Apr 20161:57 pmRNSDirectors' Dealings
15th Apr 201612:03 pmRNSAward of Share Options
15th Apr 201611:57 amRNSDirectors' Dealings
14th Apr 20167:00 amRNSDirectors' Dealings
11th Apr 20167:00 amRNSAppointment of José Barella as Chairman
4th Apr 20167:00 amRNSNotice of Preliminary Results
3rd Feb 201612:31 pmRNSHolding(s) in Company
1st Feb 20161:08 pmRNSDirector's Dealings
1st Feb 20167:00 amRNSPre-close Trading Update
20th Jan 20167:00 amRNSAppointment of Erica H. Boisvert as CFO
13th Jan 20167:00 amRNSNew Product Range Launch & Distribution Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.